Wikidata entity: Q410011
C₁₈H₁₉N₃O (P274)
Quantities
| P4250 | defined daily dose | 16 |
| P2067 | mass | 293.152812 |
| P3780 | active ingredient in | ... | Q47522352 (Zofran) | Zofran |
| P3780 | active ingredient in | ... | Q47522362 (Zuplenz) | Zuplenz |
| P3780 | active ingredient in | ... | Q112765844 (Vonau Flash) | Vonau Flash |
| P233 | canonical SMILES | String | CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C | ??? |
| P373 | Commons category | String | Ondansetron | ??? |
| P527 | has part(s) | ... | Q627 (nitrogen) | nitrogen |
| P527 | has part(s) | ... | Q623 (carbon) | carbon |
| P527 | has part(s) | ... | Q629 (oxygen) | oxygen |
| P31 | instance of | ... | Q59199015 (group of stereoisomers) | group of stereoisomers |
| P176 | manufacturer | ... | Q206921 (Pfizer) | Pfizer |
| P2175 | medical condition treated | ... | Q156103 (gastroenteritis) | gastroenteritis |
| P2175 | medical condition treated | ... | Q7331102 (alcohol abuse) | alcohol abuse |
| P129 | physically interacts with | ... | Q21108125 (5-hydroxytryptamine receptor 3A) | 5-hydroxytryptamine receptor 3A |
| P3489 | pregnancy category | ... | Q3679232 (Australian pregnancy category B1) | Australian pregnancy category B1 |
| P3489 | pregnancy category | ... | Q28123616 (US pregnancy category B) | US pregnancy category B |
| P769 | significant drug interaction | ... | Q7739 (arsenic trioxide) | arsenic trioxide |
| P769 | significant drug interaction | ... | Q41576 (cocaine) | cocaine |
| P769 | significant drug interaction | ... | Q174259 (droperidol) | droperidol |
| P769 | significant drug interaction | ... | Q179996 ((RS)-methadone) | (RS)-methadone |
| P769 | significant drug interaction | ... | Q58375 (thioridazine) | thioridazine |
| P769 | significant drug interaction | ... | Q213511 (erythromycin) | erythromycin |
| P769 | significant drug interaction | ... | Q416206 (pentamidine) | pentamidine |
| P769 | significant drug interaction | ... | Q417597 (procainamide) | procainamide |
| P769 | significant drug interaction | ... | Q417909 (terfenadine) | terfenadine |
| P769 | significant drug interaction | ... | Q419394 (sevoflurane) | sevoflurane |
| P769 | significant drug interaction | ... | Q421381 (flecainide) | flecainide |
| P769 | significant drug interaction | ... | Q421937 ((RS)-hydroxyzine) | (RS)-hydroxyzine |
| P769 | significant drug interaction | ... | Q118551 (clarithromycin) | clarithromycin |
| P769 | significant drug interaction | ... | Q228143 (zuclopenthixol) | zuclopenthixol |
| P769 | significant drug interaction | ... | Q251347 (haloperidol) | haloperidol |
| P769 | significant drug interaction | ... | Q947595 (halofantrine) | halofantrine |
| P769 | significant drug interaction | ... | Q976559 (sparfloxacin) | sparfloxacin |
| P769 | significant drug interaction | ... | Q3712521 (dofetilide) | dofetilide |
| P769 | significant drug interaction | ... | Q3791612 (ibutilide) | ibutilide |
| P769 | significant drug interaction | ... | Q3993743 ((Z)-Toremifene) | (Z)-Toremifene |
| P769 | significant drug interaction | ... | Q4890934 (bepridil) | bepridil |
| P769 | significant drug interaction | ... | Q5186964 (crizotinib) | crizotinib |
| P769 | significant drug interaction | ... | Q422418 ((RS)-sulpiride) | (RS)-sulpiride |
| P769 | significant drug interaction | ... | Q422438 (chloroquine) | chloroquine |
| P769 | significant drug interaction | ... | Q423437 (astemizole) | astemizole |
| P769 | significant drug interaction | ... | Q10354103 (probucol) | probucol |
| P769 | significant drug interaction | ... | Q269111 (apomorphine) | apomorphine |
| P769 | significant drug interaction | ... | Q407972 (chlorpromazine) | chlorpromazine |
| P769 | significant drug interaction | ... | Q144085 (pimozide) | pimozide |
| P769 | significant drug interaction | ... | Q6821618 (mesoridazine) | mesoridazine |
| P769 | significant drug interaction | ... | Q7914515 (vandetanib) | vandetanib |
| P769 | significant drug interaction | ... | Q408163 (anagrelide) | anagrelide |
| P769 | significant drug interaction | ... | Q408637 (dronedarone) | dronedarone |
| P769 | significant drug interaction | ... | Q409672 ((RS)-citalopram) | (RS)-citalopram |
| P769 | significant drug interaction | ... | Q410061 (amiodarone) | amiodarone |
| P769 | significant drug interaction | ... | Q423757 (escitalopram) | escitalopram |
| P769 | significant drug interaction | ... | Q424238 (domperidone) | domperidone |
| P769 | significant drug interaction | ... | Q412496 (quinidine) | quinidine |
| P769 | significant drug interaction | ... | Q413591 (sotalol) | sotalol |
| P769 | significant drug interaction | ... | Q165399 (azithromycin) | azithromycin |
| P769 | significant drug interaction | ... | Q424940 (moxifloxacin) | moxifloxacin |
| P769 | significant drug interaction | ... | Q425120 (disopyramide) | disopyramide |
| P769 | significant drug interaction | ... | Q425295 (cisapride) | cisapride |
| P279 | subclass of | ... | Q35456 (essential medicine) | essential medicine |
| P279 | subclass of | ... | Q1659847 (imidazole) | imidazole |
| P279 | subclass of | ... | Q55698578 (indoles) | indoles |
| P279 | subclass of | ... | Q73232281 (cyclic ketone) | cyclic ketone |
| P2868 | subject has role | ... | Q208144 (antipsychotics) | antipsychotics |
| P2868 | subject has role | ... | Q62903 (anxiolytic) | anxiolytic |
| P2868 | subject has role | ... | Q575136 (antiemetic) | antiemetic |
| P2868 | subject has role | ... | Q2853347 (antipruritic) | antipruritic |
| P2868 | subject has role | ... | Q7455047 (serotonin antagonist) | serotonin antagonist |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | ondansetron | ??? |
| P267 | ATC code | A04AA01 |
| P231 | CAS Registry Number | 99614-02-5 |
| P683 | ChEBI ID | 7773 |
| P592 | ChEMBL ID | CHEMBL46 |
| P661 | ChemSpider ID | 4434 |
| P9272 | DeCS ID | 30632 |
| P715 | DrugBank ID | DB00904 |
| P11198 | DrugCentral ID | 1992 |
| P8494 | DSSTOX compound identifier | DTXCID803393 |
| P3117 | DSSTox substance ID | DTXSID8023393 |
| P232 | EC number | 619-449-4 |
| P2566 | ECHA Substance Infocard ID | 100.110.918 |
| P9635 | electronic Essential Medicines List medicine ID | 30 |
| P646 | Freebase ID | /m/04b72x |
| P595 | Guide to Pharmacology Ligand ID | 2290 |
| P2062 | HSDB ID | 8304 |
| P2057 | Human Metabolome Database ID | HMDB0005035 |
| P234 | InChI | InChI=1S/C18H19N3O/c1-12-19-9-10-21(12)11-13-7-8-16-17(18(13)22)14-5-3-4-6-15(14)20(16)2/h3-6,9-10,13H,7-8,11H2,1-2H3 |
| P235 | InChIKey | FELGMEQIXOGIFQ-UHFFFAOYSA-N |
| P8408 | KBpedia ID | Ondansetron |
| P665 | KEGG ID | D00456 |
| P665 | KEGG ID | C07325 |
| P6689 | MassBank accession ID | SM852501 |
| P10245 | MedlinePlus drug identifier | a601209 |
| P10245 | MedlinePlus drug identifier | a606022 |
| P486 | MeSH descriptor ID | D017294 |
| P672 | MeSH tree code | D03.383.129.308.690 |
| P672 | MeSH tree code | D03.633.100.473.144.500 |
| P672 | MeSH tree code | D03.633.300.148.500 |
| P6366 | Microsoft Academic ID (discontinued) | 2777170512 |
| P950 | National Library of Spain SpMaBN ID (BNE v1.0) | XX547677 |
| P2115 | NDF-RT ID | N0000147951 |
| P2840 | NSC number | 757870 |
| P10283 | OpenAlex ID | C2777170512 |
| P4235 | PatientsLikeMe treatment ID | ondansetron |
| P11199 | Probes And Drugs ID | PD002938 |
| P662 | PubChem CID | 4595 |
| P3417 | Quora topic ID | Ondansetron |
| P3345 | RxNorm CUI | 26225 |
| P4964 | SPLASH | splash10-006x-0790000000-39dfc83ad8c54c21d83d |
| P2877 | SureChEMBL ID | 4542 |
| P2892 | UMLS CUI | C0061851 |
| P11089 | UniChem compound ID | 399967 |
| P652 | UNII | 4AF302ESOS |
| P11143 | WikiProjectMed ID | Ondansetron |
| P3350 | World Health Organisation international non-proprietary name numeric ID | 5965 |
Why not click here or view trends?
log id: 3024610